激肽释放酶(Kallikrein)家族

人类激肽释放酶相关肽酶(Kallikrein,KLKs)是一个由15个(KLK1-KLK15)成员组成的丝氨酸蛋白酶家族,它们通过复杂的级联激活网络调控着多种关键生理过程,包括皮肤脱屑、精液液化、先天免疫和神经功能。
KLKs的表达失调与多种疾病密切相关,其中在癌症,特别是前列腺癌中的作用研究最为深入。其中KLK3/PSA临床上应用最广泛的前列腺癌筛查和监测标志物,而其他成员如KLK2、KLK4、KLK14等则通过降解细胞外基质、调节生长因子和重塑肿瘤微环境,直接驱动肿瘤的增殖、侵袭和转移。
基于这些功能,KLKs已成为极具潜力的诊断工具和治疗靶点。诊断上,通过检测PSA亚型或联合检测KLK2、KLK4等成员,可提高前列腺癌诊断准确性。治疗上,已开发出KLK激活的前药。此外针对促癌KLKs(如KLK2、KLK4、KLK14)的抑制剂(如MDPK67b)的研发也展现出广阔前景。
KLK 家族分子及其生物学功能
分子 生物学功能
KLK1 血管舒缓素系统相关,调控血压与炎症反应
KLK4, KLK10, KLK11 调节上皮细胞增殖、分化与凋亡,涉及肿瘤发生发展
KLK6 参与中枢神经系统的炎症与神经退行性疾病过程
KLK2, KLK3 前列腺癌的生物标志物 / 靶向治疗
KLK5, KLK6, KLK7, KLK14 皮肤屏障蛋白酶网络核心成员,介导角质层脱屑与屏障稳态,关联炎症性皮肤病
KLK8, KLK9, KLK12, KLK13, KLK15 功能尚未完全阐明,在炎症和肿瘤进展中发挥作用
为加速KLK相关病理机制研究和药物开发研究进程,ACROBiosystems百普赛斯开发了一系列Kallikrein家族蛋白,包括Kallikrein 1Kallikrein 2Kallikrein 3Kallikrein 5Kallikrein 7Kallikrein 11 等家族系列产品。

>>>相关产品:前列腺癌热门靶点PSMA

产品特点及应用

产品特点

高纯度:经SDS-PAGE(≥95%)和SEC-MALS/HPLC验证

高酶活:酶活被纳入常规QC检测项,数据稳定可靠

高生物活性:高生物活性经ELISA验证

质量一致性:稳定保障研发过程中的质量一致性,为药物研发提供可靠支撑

产品应用

抗体发现、免疫、抗体筛选及功能验证

小分子先导化合物的筛选

利用酶切活性进行检测底物的开发

产品列表

验证数据

超90%纯度经SDS-PAGE验证
超90%纯度经SDS-PAGE验证

Human Kallikrein 2 Protein, Tag Free (Cat.No. KA2-H5214) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

超90%纯度经SDS-PAGE验证

Biotinylated Human Kallikrein 3 Protein, His,Avitag (Cat.No. KA3-H82E4)on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

超95%纯度经SEC-MALS/HPLC验证
超95%纯度度经SEC-MALS/HPLC验证

The purity of Human Kallikrein 3 Protein, His Tag (Cat. No. KL3-H52H3) is more than 95% and the molecular weight of this protein is around 25-40 kDa verified by SEC-MALS.

Protocol

超95%纯度度经SEC-MALS/HPLC验证

The purity of Human Kallikrein 1 (25-262) Protein, His Tag (Cat. No. KL1-H52H4) was greater than 95% as determined by SEC-HPLC.

Protocol

高酶活
测定产品 Human Kallikrein 2 Protein, Tag Free (active enzyme)
(Cat.No.KA2-H5214)
Human Kallikrein 2 Protein, His Tag (active enzyme)
(Cat.No.KA2-H52H3)
水解底物 Pro-Phe-Arg-7-amido-4-methylcoumarin (PFR-AMC)
酶活
(pmol/min/μg)
>450 >150
测定产品 Biotinylated Human Kallikrein 3 Protein, His,Avitag™
(active enzyme, MALS verified)
(Cat.No.KA3-H82E4)
Human Kallikrein 3 Protein, His Tag (Pro-form, MALS verified)
(Cat.No.KL3-H52H3)
水解底物 Succinyl-Arg-Pro-Tyr-p-Nitroanilide (SucRPYpNA)
酶活
(pmol/min/μg)
>160 >150
测定产品 Human Kallikrein 5 Protein, Tag Free (active enzyme)
(Cat.No.KA5-H5213)
Human Kallikrein 7 Protein, Tag Free (active enzyme)
(Cat.No.KA7-H5213)
水解底物 BOC-Val-Pro-Arg-AMC Mca-RPKPVE-Nval-WRK(Dnp)-NH2
酶活
(pmol/min/μg)
>350 >150
与抗体的结合活性经ELISA验证
与抗体的结合活性经ELISA验证

Immobilized Human Kallikrein 2 Protein, Tag Free (Cat. No. KA2-H5214) at 1 μg/mL (100 μL/well) can bind Human KLK2 Antibody with a linear range of 0.1-8 ng/mL (Routinely tested).

Protocol

与抗体的结合活性经ELISA验证

Immobilized Human Kallikrein 2 Protein, His Tag (Cat. No. KA2-H52H3) at 1 μg/mL (100 μL/well) can bind Human KLK2 Antibody, IgG with a linear range of 0.06-2 ng/mL (Routinely tested).

Protocol

相关产品推荐

相关阅读

KLK2:前列腺癌治疗新星

  • 背景
  • 产品特点及应用
  • 产品列表
  • 验证数据
  • 相关产品推荐
  • 相关阅读